Neystat, M; Lynch, T; Przedborski, S et al. (1999) Alpha-synuclein expression in substantia nigra and cortex in Parkinson's disease. Mov Disord 14:417-22
|
Przedborski, S; Jackson-Lewis, V (1998) Mechanisms of MPTP toxicity. Mov Disord 13 Suppl 1:35-8
|
Jakowec, M W; Jackson-Lewis, V; Chen, X et al. (1998) The postnatal development of AMPA receptor subunits in the basal ganglia of the rat. Dev Neurosci 20:19-33
|
Sterneck, E; Paylor, R; Jackson-Lewis, V et al. (1998) Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein delta. Proc Natl Acad Sci U S A 95:10908-13
|
Przedborski, S; Jackson-Lewis, V (1998) Experimental developments in movement disorders: update on proposed free radical mechanisms. Curr Opin Neurol 11:335-9
|
Kostic, V; Jackson-Lewis, V; de Bilbao, F et al. (1997) Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277:559-62
|
Mena, M A; Khan, U; Togasaki, D M et al. (1997) Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture. J Neurochem 69:21-33
|
Takahashi, N; Miner, L L; Sora, I et al. (1997) VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proc Natl Acad Sci U S A 94:9938-43
|
Przedborski, S; Jackson-Lewis, V; Yokoyama, R et al. (1996) Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Proc Natl Acad Sci U S A 93:4565-71
|
Przedborski, S; Dhawan, V; Donaldson, D M et al. (1996) Nigrostriatal dopaminergic function in familial amyotrophic lateral sclerosis patients with and without copper/zinc superoxide dismutase mutations. Neurology 47:1546-51
|
Showing the most recent 10 out of 15 publications